Bausch+Lomb Results Presentation Deck
Pipeline and Upcoming Milestones¹
Vision Care
Product
SiHy Daily
Lacelle® colored contact lenses
Biotrue® Hydration Plus Multi-purpose
Solution
Biotrue® PF Contact Lens Rehydrating
Drops (Multidose & Single Dose Use)
LUMIFY® Line Extensions
Myopia control contact lens²
BAUSCH + LOMB
Status
Launched in ~25 countries
Approved in Japan
Approved (US FDA, Health Canada, NMPA/
China)
Design transfer and Commercialization
Readiness stage
Phase 3 study in progress
Myopia control contact lens design licensed
from BHVI
1. See slide 1 for further information on forward-looking statements.
2. Exclusive licensing agreement with BHVI.
Upcoming Milestone
Launching SVS into more countries in 2022;
Multi-focal and toric launch coming 2022-2023
New range of Daily Disposable cosmetic lens
launching in Japan summer 2022
U.S. launch ongoing; Canada launch expected
2H22 and China launch expected 1H23
U.S. FDA submission expected 2022, launch
mid-2023
One phase 3 clinical study started. Additional
studies to start in 2H22
Global Clinical Strategy updated and finalizing
clinical trial design
23View entire presentation